Read More Pharma Industry News Checkpoint inhibitors in early-stage cancer: A new era of adjuvant therapy is taking shape Checkpoint inhibitors are redefining early-stage cancer care. Find out how Tecentriq, Keytruda, and others are competing for the adjuvant immunotherapy market. byPallavi MadhirajuJune 4, 2025